SCHEMBL7649274

SCHEMBL7649274

O=c1[nH]c2cc(Cl)c(S(=O)(=O)NC3CC3)cc2cc1P(=O)(O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.38
PARG Q86W56 1/20 0.37
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
HDAC8 Q9BY41 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIA1 P42261 1/20 0.32
GRIA2 P42262 1/20 0.32
GRIA3 P42263 1/20 0.32
GRIA4 P48058 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7648730 0.84 GRIN2D (0.35) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL7647474 0.84 ALDH1A1 (0.38) BRD4PARGALDH1A1SMN1; SMN2LMNA
SCHEMBL6939746 0.83 GRIN2D (0.37) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL7648786 0.83 GRIN1 (0.35) ALDH1A1LMNAPOLBGRIN2DGRIN3B
SCHEMBL7647481 0.83 SMN1; SMN2 (0.35) BRD4PARGALDH1A1SMN1; SMN2LMNA
SCHEMBL7652655 0.81 GSTO1 (0.37) ALDH1A1GRIN2DGRIN3BGRIA1GRIA2
SCHEMBL7652701 0.81 KDM4E (0.37) ALDH1A1POLBTSHRGRIN2DGRIN3B
SCHEMBL2844839 0.79 CA12 (0.40) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL6939707 0.79 POLB (0.36) ALDH1A1L3MBTL1POLBTSHRGRIN2D
SCHEMBL6940873 0.79 WDR5 (0.45) BRD4LMNAMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 BRD4 1926/4885PARG 4287/4885ALDH1A1 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.